We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Prescribing Tool Checks for Potentially Dangerous Drug Interactions During COVID-19 Pandemic

News   Apr 21, 2020 | Original story from The Arizona Center for Education and Research on Therapeutics (AZCERT)

 
Prescribing Tool Checks for Potentially Dangerous Drug Interactions During COVID-19 Pandemic
 
 
Advertisement
 

RELATED ARTICLES

Hydroxychloroquine Trial Revived by WHO as Doubt Cast on Lancet, NEJM Studies

News

Testing of the malaria drug hydroxychloroquine as a treatment for COVID-19 has been restarted by the WHO after researchers raised concerns about the paper, published in The Lancet two weeks ago, that first suggested the drug was linked to reduced survival and a higher risk of heart-related side effects.

READ MORE

Food and Drug Allergy Anaphylaxis Could Be Prevented With a Pill

News

A new study suggested a pill could be taken proactively to prevent mild to life-threatening anaphylaxis.

READ MORE

Clinical Trials in an Era of Digital Engagement

News

Researchers from SWOG Cancer Research Network pose provocative questions aimed at sparking discussion and creating consensus on how cancer clinical trial stakeholders can best interact on social platforms.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE